Pove was generally safe and well tolerated with adverse events (AEs) that were mostly mild or moderate in severity. There were no serious adverse events related to povetacicept. The safety data is ...

After navigating a high school journey that included Covid lockdowns in 2020 and extended flooding in 2022, the Class of 2025 has finished and received their HSC results on 18 December. This year’s ...